Smartleaf Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Smartleaf Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-112	Closed	-$3.41K	–	3502
2026 Q1	$3.41K	Sell	112 -59	-35%	-$2.31K	﹤0.01%	2798
2025 Q4	$7.92K	Buy	171 +40	+31%	+$2.19K	﹤0.01%	2490
2025 Q3	$8.93K	Buy	131 +69	+111%	+$5.12K	﹤0.01%	2164
2025 Q2	$5.16K	Buy	+62	New	+$4.64K	﹤0.01%	2039
2024 Q4	–	Sell	-9	Closed	-$442	–	3006
2024 Q3	$442	Buy	+9	New	+$431	﹤0.01%	2794

Smartleaf Asset Management's SLNO Position: Q2 2026 in Review

Smartleaf Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 112 shares — an estimated $3.41K sold.

Smartleaf Asset Management first reported a position in SLNO in Q3 2024 and held it in 5 quarters. The position peaked at $8.93K in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Smartleaf Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Smartleaf Asset Management sold 112 Soleno Therapeutics shares in Q2 2026, an estimated $3.41K.
Smartleaf Asset Management first reported a position in Soleno Therapeutics in Q3 2024 and held it in 5 quarters.
Smartleaf Asset Management's Soleno Therapeutics position peaked at $8.93K in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.